Results 141 to 150 of about 25,486 (236)

[Corrigendum] Ursolic acid protects against cisplatin‑induced ototoxicity by inhibiting oxidative stress and TRPV1‑mediated Ca²⁺‑signaling. [PDF]

Int J Mol Med
Di Y, Xu T, Tian Y, Ma T, Qu D, Wang Y, Lin Y, Bao D, Yu L, Liu S, Wang A.   +10 more
europepmc   +1 more source

Liposome-Encapsulated Rutin Attenuates Cisplatin-Induced Ototoxicity via Suppression of P53-Associated Oxidative Injury. [PDF]

Biomater Res
Liu B, Tu Y, Li X, Yu W, Zou W, Tang W, Zong S, Tan S, Xiao H.   +8 more
europepmc   +1 more source

Distortion product otoacoustic emission (DPOAE) reveals hearing loss up to 16 kHz in pediatric chemotherapy patients. [PDF]

Sci Rep
Hecker DJ, Remke MKH, Linxweiler M, Furtwängler R, Akrasu Y, Schöndorf D, Graf N, Krieter D, Oberkircher N, Schick B, Bozzato A, Simon A.   +11 more
europepmc   +1 more source

Correction to "Lycium barbarum Glycopeptide Alleviates Neomycin-Induced Ototoxicity by Inhibiting Tryptophan Hydroxylase-Mediated Serotonin Biosynthesis". [PDF]

Adv Sci (Weinh)
europepmc   +1 more source

Unraveling Endocannabinoid Signaling Pathways in Cisplatin-Induced Ototoxicity. [PDF]

FASEB J
Palaniappan S, Tisi A, Di Meo C, Urbano C, Fenton GE, Della Valle F, Fanti F, Compagnone D, Nazarè M, Versnel H, Aramini A, Allegretti M, Maccarrone M.   +12 more
europepmc   +1 more source

Pharmacologic Inhibition of JAK1/2 Potentiates Aminoglycoside-Induced Ototoxicity. [PDF]

Otol Neurotol
Fleegel J, Ezzat I, Vijayakumar S, Zallocchi M, Zuo J.   +4 more
europepmc   +1 more source

Monitoring Ototoxicity in Cancer Patients Undergoing Platinum-Based Chemotherapy and Radiation in Saudi Arabia: Challenges and Solutions. [PDF]

J Multidiscip Healthc
AlJasser A.
europepmc   +1 more source

Bortezomib-Induced Sensorineural Hearing Loss May Be Reversible with Intratympanic Dexamethasone. [PDF]

Hematol Rep
Peláez Casillas N, Verdaguer Muñoz JM, Rodríguez Valiente A, Romera Martínez I, García Berrocal JR.   +4 more
europepmc   +1 more source

Eleutheroside E alleviates cisplatin-induced ototoxicity by down-regulating MAPK/NF-κB/NLRP3 signaling pathway and inhibiting cochlear cell pyroptosis. [PDF]

Commun Biol
Zhang Y, Lu L, Tong B, Wang J, Liu K, Zhang J, Zhang D, Tian M, Sun W, Liu H, Wang P, Duan M, Tang Y.   +12 more
europepmc   +1 more source

Ototoxicity [PDF]

Proceedings of the Royal Society of Medicine, 1973
openaire   +1 more source